SOMESThesia and ALIMentation
SOMEST'ALIM
SOMESThesia in Patients With Head and Neck Cancer: Variability and Influence on the ALIMentation Experience
1 other identifier
interventional
72
1 country
2
Brief Summary
Cancer patients are at high risk for undernutrition. A study with head and neck cancer patients showed that 50% suffered from undernutrition (Prevost et al., 2014). Sensory alterations may also involve sensory changes from the physiological structures of the mouth or neural pathways and hedonic changes, i.e., although food may taste the same as usual, that taste is no longer judged as pleasant. These changes lead to an aversion to food and a decrease in the pleasure of eating (Bernhardson et al., 2009). Despite the large number of published studies on taste and smell alterations in diverse cancer populations, few have examined other dimensions of oral sensory alterations. Studies focusing on somesthesia have mostly been conducted in the area of oral physiology or stomatology in relation to oral pain and rehabilitation (Howes, Wongsriruksa, Laughlin, Witchel, \& Miodownik, 2014). Regarding food perception, somesthesia provides information about both texture, temperature, and trigeminal sensations. These sensations are detected by mechanical, thermal, nociceptive receptors present throughout the oral epithelium (Simons \& Carstens, 2008). In addition to taste and smell, food perception is influenced by oral somatosensation and studies have demonstrated an interrelated relationship between these oral sensations (Spence, Piqueras-Fiszman 2016). Therefore, ther might have a correlation between oral somatosensation and food preferences, subsequently influencing eating behavior and food consumption. A standard method, using a so-called Von Frey Hair monofilament, to assess tactile sensation was developed by Etter et al. (Etter, N. M et al.,. J. Vis. Exp. 2020) but has so far been only minimally used in Ear, Nose and Throat (ENT) cancer (Bearelly, Wang, \& Cheung, 2017; Bodin, Jäghagen, \& Isberg, 2004; Elfring, Boliek, Seikaly, Harris, \& Rieger, 2012). The aim of the study is to determine the variability and role of somatosensory perception (texture, pungency transmitted through the trigeminal system, and temperature) on food preferences in cancer patients compared to healthy volunteers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2022
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 14, 2022
CompletedFirst Posted
Study publicly available on registry
March 10, 2022
CompletedStudy Start
First participant enrolled
May 20, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 14, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 14, 2023
CompletedSeptember 9, 2025
September 1, 2025
11 months
February 14, 2022
September 2, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Oral tactile sensitivity score
The primary endpoint of the study is to measure oral tactile sensitivity using the Von Frey Hair monofilament pressure test in head and neck cancer patients compared to healthy volunteers. This will be assessed at recruitment for healthy volunteers and between 1 to 3 months after recruitment for head and neck cancer patients.
Up to 3 months after recruitment.
Secondary Outcomes (7)
thermic sensitivity score
Up to 3 months after recruitment.
trigeminal sensitivity score
Up to 3 months after inclusion.
texture sensitivity score
Up to 3 months after recruitment.
salivary function
Up to 3 months after recruitment.
food preference score
Up to 3 months after recruitment.
- +2 more secondary outcomes
Study Arms (3)
head and neck cancer patients with radiotherapy AND chemotherapy
EXPERIMENTALpatients included for a head and neck cancer and treated by radiotherapy (+/- surgery) + chemotherapy
head and neck cancer patients with radiotherapy only
EXPERIMENTALpatients included for a head and neck cancer and treated by radiotherapy (+/- surgery) without chemotherapy
healthy volunteers
ACTIVE COMPARATORhealthy volunteers paired with experimental patients on age (+/- 5 years), gender, tobacco status
Interventions
Patients will be included in the study between 3 to 6 months after the end of treatment and go to the Paul Bocuse Research Institute to perform several sensorial tests. The same sensorial tests will be completed by healthy volunteers to compare.
Patients will be included in the study between 3 to 6 months after the end of treatment and go at Institut Paul Bocuse to complete food preferences questionnaires. The same questionnaires will be completed by healthy volunteers to compare.
Eligibility Criteria
You may qualify if:
- All subjects:
- Person between 18 and 65 years
- Person having given free, informed, express written consent
- Person affiliated to a French social security system
- Person with a body mass superior to 18 kg/m².
- Person able to come once to the Institut Paul Bocuse
- Patients with head and neck cancer with chemotherapy:
- \- Patient diagnosed with squamous cell head and neck cancer with the following treatment regimen: Surgery + radiochemotherapy or radiochemotherapy alone
- Patients with head and neck cancer without chemotherapy:
- \- Patient diagnosed with squamous cell head and neck cancer with the following treatment regimen: Surgery + radiation therapy or radiation therapy alone
- Healthy volunteers :
- Volunteer who is +/- 5 years of age relative to the patient to whom they are matched.
- Volunteer of the same sex as the patient to whom they are matched
- Volunteer with the same smoking status as the patient to whom they are matched
- Volunteer with no current treatment that may affect taste and smell perception
You may not qualify if:
- All subjects:
- Person with a known food allergy/intolerance (lactose or milk protein) or unable to consume dairy or solid products (e.g., chocolate milk pudding, chocolate jelly)
- Person with a known allergy to chili (or capsaicin)
- Person with diagnosed total ageusia
- Person with diagnosed total anosmia
- Person deprived of liberty or under guardianship or trusteeship.
- Pregnant or breastfeeding woman
- Person deprived of liberty by a judicial or administrative decision
- Person under guardianship or protection of vulnerable adults
- Person with trismus (reduced jaw opening or limited jaw range of motion)
- A person who is unable to extend his or her tongue
- Person who has had surgery on the mobile tongue and/or base of the tongue
- Person unable to swallow soft foods
- Person who has had or is suspected of having had Corona Virus Disease (COVID)-19 within the last 6 months.
- Patients with head and neck cancer:
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Centre de recherche de l'Institut Paul Bocuse
Écully, 69131, France
Service d'Oncologie médicale, Hôpital de la Croix-Rousse
Lyon, 69004, France
Related Publications (1)
Riantiningtyas RR, Valenti A, Dougkas A, Bredie WLP, Kwiecien C, Bruyas A, Giboreau A, Carrouel F. Oral somatosensory alterations and salivary dysfunction in head and neck cancer patients. Support Care Cancer. 2023 Oct 13;31(12):627. doi: 10.1007/s00520-023-08086-7.
PMID: 37828382BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Amandine BRUYAS
Hospices Civils de Lyon
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 14, 2022
First Posted
March 10, 2022
Study Start
May 20, 2022
Primary Completion
April 14, 2023
Study Completion
April 14, 2023
Last Updated
September 9, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share